Related Experiment Videos
A comparison of five manually operated coagulation instruments
American Journal of Clinical Pathology
|July 1, 1978
Summary
This study compared coagulation analyzers for activated partial thromboplastin time (APTT) and prothrombin time (PT). The Coag-a-Mate and Electra 650 showed excellent precision and reproducibility for APTT measurements.
Area of Science:
- Clinical Chemistry
- Hematology
- Medical Diagnostics
Background:
- Accurate coagulation testing is crucial for patient management.
- Several automated instruments are available for prothrombin time (PT) and activated partial thromboplastin time (APTT) analysis.
- Evaluating instrument performance is essential for reliable laboratory results.
Purpose of the Study:
- To compare the precision, reproducibility, and accuracy of five different coagulation instruments.
- To assess the performance of single-channel analyzers against a reference instrument.
- To identify instruments suitable for routine clinical use.
Main Methods:
- Comparative analysis of PT and APTT results from Coag-a-Mate, Coagulyzer Jr., Clotek, Electra 650, and Fibrometer.
- Evaluation of precision using coefficient of variation (CV).
- Assessment of day-to-day reproducibility and correlation with a reference instrument (Bio/Data CA-15).
Main Results:
- No significant differences were observed among instruments for PT analysis.
- The single-channel Coag-a-Mate demonstrated the best APTT precision (CV 2-4%).
- Coag-a-Mate and Electra 650 exhibited the best APTT day-to-day reproducibility (CV 2-5%).
- Good correlation (r ≥ 0.95) was found between the reference instrument and Coag-a-Mate, Electra 650, and Clotek.
- Coagulyzer Jr. showed good correlation (r = 0.95) but missed some clots. Fibrometer had poorer correlation (r = 0.87).
Conclusions:
- Coag-a-Mate and Electra 650 are reliable instruments for APTT testing, offering good precision and reproducibility.
- Most evaluated instruments, except Fibrometer, provide acceptable PT and APTT results.
- Instrument selection should consider specific performance characteristics, including clot detection capabilities.